The global AI in Drug Discovery market study report provides an exclusive analysis of the current market size and future growth opportunities. This comprehensive study on the global AI in Drug Discovery market provides brief guidance to the market vendors, stakeholders, participants, and emerging players on dealing with the post-pandemic market downfall. In this latest report, our researchers have provided valuable insight into market dynamics to business strategists, investors, industrial leaders, and stakeholders during the forecast period 2026-2035. The market report highlights the current market value, emerging trends, and projected growth rate for the upcoming years.
In addition to market trends, the market study report also features an analysis of the COVID-19 impact on major segments covered in the market. Our study report also provides insightful information on current and future growth predictions, along with the impact of a pandemic on the overall growth of the industry.
AI in Drug Discovery Market Overview
The global AI in drug discovery market, valued at USD 6.0 billion in 2025, is projected to reach USD 8.6 billion in 2026 and USD 25.0 billion by 2035, representing a CAGR of 12.6% during the forecast period 2026 to 2035. Since the approval of Soliris® in 2007, an anti-C5 antibody, the field of complement drug discovery has gained significant attention.
Key market aspects studied in the report:
Market Scope: The report explains the scope of various commercial possibilities in the global AI in Drug Discovery market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.
Competitive Outlook: The leading companies operating in the AI in Drug Discovery market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.
Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global AI in Drug Discovery market.
Competitive Terrain:
The global AI in Drug Discovery industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.
Â
The titled segments and sub-section of the AI in Drug Discovery Market are illuminated below:
Leading Market Players Profiled in the Report:
Aiforia Technologies, Atomwise, BioSyntagma, Chemalive, Collaborations Pharmaceuticals, Cyclica, DeepMatter, Exscientia, InveniAI, MAbSilico, Optibrium, Recursion Pharmaceuticals, Sensyne Health and Valo Health.
Regional Outlook:
To access the full coverage of the global AI in Drug Discovery market report, visit @ https://www.rootsanalysis.com/reports/ai-based-drug-discovery-market.html
Key reasons to buy the Global AI in Drug Discovery Market report:
Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.